Sign in

CIK 0001108205 · Non-accelerated filer<br>Smaller reporting company

CURIS INC

Sign in to watch
Ticker
CRIS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
043505116
Phone
617-503-6500
Business address
128 SPRING STREET, BUILDING C, SUITE 500, LEXINGTON, MA, 02421
  1. 4 Open-market sale CEO and Director sold 126,852 shares at an average $3.68 ($466,552)
  2. 4/A Open-market sale CEO and Director sold 175,000 shares at an average $3.69 ($645,050)
  3. 4 Option exercise CFO acquired 50,000 shares (option exercise)
  4. 4 Option exercise Director acquired 62,500 shares (option exercise)
  5. 4 Open-market sale CEO and Director sold 175,000 shares at an average $3.69 ($645,050)
  6. ARS Other Annual Report to Security Holders
  7. 4 Open-market sale Director sold 60,000 shares at $3.67 ($220,200)
  8. 4 Open-market sale VP, Tech Management sold 70,000 shares at $3.66 ($256,200)
  9. 8-K Event Results of operations · Executive or director change
  10. DEFA14A Proxy Proxy Materials
  11. DEF 14A Proxy Proxy Statement
  12. CT ORDER Other Confidential Order
  13. PRE 14A Proxy Proxy Statement (Preliminary)
  14. 4 Derivatives Options or other derivatives
  15. 10-K Report Annual Report
  16. 3 Insider Initial Statement of Ownership
  17. 8-K Event Executive or director change · Other events
  18. 8-K Event Executive or director change · Other events
  19. 4 Derivatives Options or other derivatives
  20. 3 Insider Initial Statement of Ownership

Page 31 of 61 · 1,213 filings